Finch Therapeutics & Takeda Expand Collaboration to Develop Microbiome...
Finch & Takeda to target Crohns disease under expanded collaborationFinch Therapeutics Group Inc. Finch and Takeda Pharmaceutical Company Limited Takeda; TSE4502NYSETAK announced today the...
View ArticleFinch Therapeutics and Takeda Expand Collaboration to Develop Microbiome...
SOMERVILLE Mass.&8211;BUSINESS WIRE&8211;Finch Therapeutics Group Inc. Finch and Takeda Pharmaceutical Company Limited Takeda; TSE4502NYSETAK announced today the expansion of their...
View ArticleHow Crohn's diseaseassociated bacteria tolerate antibiotics
PLOS Bacteria associated with Crohn's disease rely on multiple stress responses to survive multiply and tolerate antibiotics within white blood cells called macrophages according to a study published...
View ArticlePredictImmune Pleased to Announce the Appointment of James Clark as Chief...
PredictImmune developers of pioneering prognostic tools for guiding treatment options and improving patient outcomes in immunemediated diseases is delighted to welcome James Clark as Chief Technology...
View ArticleFinch Therapeutics Takeda expand collaboration to develop microbiome...
Under the terms of the expanded agreement Finch and Takeda will utilize Finchs platform to target Crohns disease a form of inflammatory bowel disease. Finchs HumanFirst Discovery platform The post...
View ArticleFDA Approves Pfizers Biosimilar ABRILADA adalimumabafzb for Multiple...
Pfizer Inc. NYSE PFE today announced the United States U.S. Food and Drug Administration FDA has approved ABRILADA adalimumabafzb as a biosimilar to Humira adalimumab1 for the treatment of certain...
View ArticleFDA Approves Pfizer's ABRILADA Fifth Biosimilar To Humira
Pfizer Inc.'s PFE ABRILADA a biosimilar to Humira has received FDA approval for the treatment of certain patients with rheumatoid arthritis juvenile idiopathic arthritis psoriatic arthritis ankylosing...
View ArticlePfizer's Humira biosimilar secures FDA approval due to launch in 2023
Pfizer has confirmed the FDA approval of Abrilada adalimumabafzb its biosimilar version of AbbVies Humira the worlds bestselling drug Pfizers therapy is now authorised for use in all approved...
View ArticleFDA Approves Pfizers Biosimilar Abrilada adalimumabafzb for Multiple...
NEW YORK&8211;BUSINESS WIRE&8211;Pfizer Inc. NYSE PFE today announced the United States U.S. Food and Drug Administration FDA has approved ABRILADAÂadalimumabafzb as a biosimilar to...
View ArticleThetis Pharmaceuticals Receives Funding from the Crohn's & Colitis Foundation...
Crohn&39;s & Colitis Foundation&39;s IBD Ventures award supports development of Thetis&39; novel firstinclass Resolvin oral therapy TP317 for treatment of ulcerative colitis and...
View ArticleInflammatory Bowel Disease Insight Report Current Therapies Drug Pipeline and...
Inflammatory bowel disease IBD is an umbrella term for two conditions Crohns disease and ulcerative colitis that are characterized by chronic inflammation of the gastrointestinal GI tract. This chronic...
View ArticleVirome of the healthy human gut and how it changes during Crohns disease...
Virome of the healthy human gut and how it changes during Crohn’s disease httpbit.ly35hrIOJ NBThighlight
View Article180 Medical is Proud to Announce Being Recognized as One of the Best Places...
180 Medical a leading nationwide supplier specializing in catheters ostomy supplies incontinence products and related disposable medical supplies is proud to announce they have been named one of the...
View ArticleTiziana Life Sciences Plc TILS Financial and Strategic SWOT Analysis Review...
Tiziana Life Sciences Plc TILS Financial and Strategic SWOT Analysis Review provides you an indepth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by...
View ArticleRho Associated Protein Kinase 1 Renal Carcinoma Antigen NY REN 35 or Rho...
Rho Associated Protein Kinase 1 Renal Carcinoma Antigen NY REN 35 or Rho Associated Coiled Coil Containing Protein Kinase 1 or p160 ROCK 1 or ROCK1 or EC 2.7.11.1 Pipeline Review H1 2019SummaryRho...
View ArticleIntegrin Alpha 4 CD49 Antigen Like Family Member D or VLA4 Subunit Alpha or...
Integrin Alpha 4 CD49 Antigen Like Family Member D or VLA4 Subunit Alpha or CD49d or ITGA4 Pipeline Review H1 2019SummaryIntegrin Alpha 4 CD49 Antigen Like Family Member D or VLA4 Subunit Alpha or...
View ArticleGranulocyte Macrophage Colony Stimulating Factor Receptor Subunit Alpha...
Granulocyte Macrophage Colony Stimulating Factor Receptor Subunit Alpha Pipeline Review H2 2019SummaryGranulocyte Macrophage Colony Stimulating Factor Receptor Subunit Alpha CDw116 or CD116 or CSF2RA...
View ArticleSurgery for Ulcerative Colitis
Source Crohn's & Colitis Foundation of AmericaRelated MedlinePlus Pages Ulcerative Colitis
View ArticleCrohn's DiseaseAssociated Bacteria Tolerate Antibiotics
&160;Crohn's disease is a chronic disease that causes inflammation and irritation in the digestive tract. The disease is characterized by...
View ArticleIntegrin Alpha 4 Pipeline Review H2 2019 Published by Global Markets Direct...
Integrin Alpha 4 Pipeline Review H2 2019SummaryIntegrin Alpha 4 CD49 Antigen Like Family Member D or VLA4 Subunit Alpha or CD49d or ITGA4 pipeline Target constitutes close to 16 molecules. The latest...
View Article